Rapitus Uses, Dosage, Side Effects and more
Rapitus is under investigation in clinical trial NCT01573663 (A Drug-Drug Interaction Study of Ambroxol and Rapitus).
| Trade Name | Rapitus |
| Generic | Levodropropizine |
| Levodropropizine Other Names | levodropropizina, Levodropropizine |
| Weight | 30mg |
| Type | Syrup |
| Formula | C13H20N2O2 |
| Weight | Average: 236.315 Monoisotopic: 236.152477892 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | Macleods Pharmaceuticals |
| Available Country | India |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Rapitus is a peripherally-acting antitussive agent.
Rapitus is also used to associated treatment for these conditions: Cough
